Career history of James H. Coleman
Former positions of James H. Coleman
| Companies | Position | Start | End |
|---|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Corporate Officer/Principal | 2011-06-19 | 2012-08-09 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | Corporate Officer/Principal | 1995-12-31 | - |
Diversified Healthcare Management, Inc.
 Diversified Healthcare Management, Inc. Medical/Nursing ServicesHealth Services Diversified Healthcare Management, Inc. is an American company that owns and operates physician hospitals. The private company was founded by James H. Coleman. | Founder | 1996-12-31 | - |
| President | 1996-12-31 | - |
Training of James H. Coleman
| University of Rhode Island | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| President | 1 |
Sectoral
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Diversified Healthcare Management, Inc.
Diversified Healthcare Management, Inc. Medical/Nursing ServicesHealth Services Diversified Healthcare Management, Inc. is an American company that owns and operates physician hospitals. The private company was founded by James H. Coleman. | Health Services |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | Health Technology |
- Stock Market
- Insiders
- James H. Coleman
- Experience
